Rexulti falls short of goal in late-stage bipolar disorder studies
Lundbeck’s Rexulti has failed to achieve the primary endpoint of two Phase III bipolar disorder studies.
Read More
Tag: bipolar
Statins may help treat serious mental illness
Statins could bring significant benefits to people with serious mental illnesses such as schizophrenia, bipolar disorder or non-affective psychoses, indicate new findings from UCL-led research.
Read More
MHRA bans valproate without pregnancy prevention programme
The Medicines and Healthcare products Regulatory Agency (MHRA) has changed the licence for valproate medicines, so that they can no longer be prescribed to females of child-bearing age unless they are on the pregnancy prevention programme.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
